LifeMD includes sermorelin injection within a broader men’s health program that also discusses testosterone-related care. The page offers an online clinical pathway, but its general program headings should not be treated as the approval status or treatment instructions for every individual product listed beneath them.
This review examines public material checked on September 20, 2026. We did not book a visit, purchase medicine, or verify an individual prescription. CoreAge Rx receives commercial placement on this site; the purpose here is to identify LifeMD’s published information and the details a patient should clarify before proceeding.
LifeMD identifies sermorelin as compounded and not FDA-approved. Clarify the conflicting route text and obtain a product-specific care plan and quote.
A broad men’s health program is not one treatment
The page places sermorelin alongside several testosterone-related products. These medicines address different pathways and may have different indications, risks, and monitoring needs. A broad interest in hormone care does not establish that each option is appropriate for the same patient.
Begin with the actual concern and ask what diagnosis the clinician is evaluating. If low testosterone is suspected, that requires its own assessment; a sermorelin prescription is not automatically an alternative treatment for that diagnosis. Our testosterone and TRT article explains why two hormone-related products should not be treated as substitutes simply because they appear on one program page.
The specific approval disclosure matters
LifeMD uses broad language about access to FDA-approved treatment options, but it separately states that sermorelin is a compounded product that has not been FDA-approved or evaluated for safety, efficacy, or quality. That product-specific disclosure is the relevant one for this review.
Do not infer approval from an adjacent medicine, a general heading, or a clinician's prescription. Historical GEREF products do not confer approval on a current compounded preparation either. The FDA-approval guide explains how those statements can coexist without making the compounded product an approved generic.
The route descriptions need reconciliation
The product card labels sermorelin injection as intramuscular, while the later safety text refers to subcutaneous, or SC, administration. This is a meaningful inconsistency to resolve with the clinician and pharmacy. We do not choose one website statement as the instruction for a patient's prescription.
Ask for a written route and directions tied to the actual preparation. Do not switch between injection routes or use a generic tutorial to fill the gap. The injection-safety guide emphasizes matching the label, supplies, and prescribed instructions before home use. A clear answer matters more than assuming a familiar route from another provider.
Ask how the video visit and testing apply to sermorelin
The broader program describes an intake and a video visit with a licensed provider. It also discusses laboratory orders and treatment in one care setting. Confirm which elements apply to the proposed sermorelin assessment and which are features of another program on the same page.
Ask whether recent records can be reviewed, what additional testing is clinically useful, and who explains the results. A larger list of tests does not automatically establish better care. The laboratory guide explains why IGF-1 is only part of the assessment and why the goal is a useful clinical decision rather than a more impressive-looking panel.
The complete price remains a separate question
We did not establish an all-in sermorelin price from the reviewed program page. Request an itemized quote for the initial assessment, laboratory work, medication, supplies, shipping, and follow-up. Identify any membership or recurring charge if it is part of the selected arrangement.
Do not substitute a testosterone-program amount or another LifeMD service price for a sermorelin quote. Ask what is charged if no prescription is issued and how a later change in the clinical plan affects billing. Our cost guide helps compare an actual care period with another provider's advertised starting rate without pretending the two figures describe identical services.
Name the pharmacy and finished preparation
Before a prescription is filled, confirm which pharmacy will dispense it and what the preparation contains. A program logo does not identify the legal dispensing entity, the concentration, or the beyond-use instructions. If the pharmacy or formulation changes at refill, ask for updated directions.
Keep that information accessible for questions about storage, a delivery problem, or a possible reaction. The pharmacy checklist and vial-label guide help organize the details. This review has not inspected LifeMD's pharmacy arrangements or established the quality of a particular lot.
Evaluate the intended benefit and follow-up
A patient looking for better energy or recovery needs a clear explanation of what the treatment is intended to improve. Ask what evidence supports the proposed use and what would trigger reassessment. A clinical pathway should leave room for investigating another cause or recommending a different treatment.
If the main concern is fatigue, sleepiness, or new headaches, tell the clinician rather than treating those symptoms as proof of hormone deficiency. Our fatigue guide and sleep-apnea guide explain why symptom-specific evaluation matters. Also establish how to obtain help between visits if a new concern develops after treatment begins.
Our assessment and a fair comparison
LifeMD's program may be relevant to someone seeking a broader men's health assessment, but the public page does not settle the exact sermorelin prescription, total cost, or follow-up arrangement. The route inconsistency should be resolved before administration, and the compounded-product disclosure should remain visible when interpreting general program language.
Compare a written plan with the CoreAge Rx review or the separate-fee model in our Lavender Sky Health review. Use the same questions and the same period of care. This review does not establish that any provider's preparation is more effective or safer than another's.
Sources behind this article
Provider pages describe their own services. They are not independent proof of health outcomes. Pricing and availability can change.
- LifeMD: Men’s health programProvider program page · Contains a sermorelin compounded-product disclosure. Product card and safety text differ on route; no complete sermorelin quote verified.
- Endocrine Society: Testosterone therapy guidelineClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
- FDA: 2013 GEREF withdrawal determinationFederal Register / FDA · Historical GEREF products were not withdrawn for safety or effectiveness reasons; this does not approve current compounds.
- FDA: Compounding questions and answersUS regulator · Compounded medicines differ from FDA-approved generic drugs.
- Mayo Clinic: Sermorelin injection informationClinical or regulatory reference · Checked September 20, 2026. Findings apply to the specified molecule, route, and population.
- Endocrine Society: Adult growth hormone deficiencyClinical practice guideline · Diagnosis and treatment of established deficiency; not an endorsement of anti-aging prescribing.
- FDA: Managing the benefits and risks of medicinesUS regulator · General questions for evaluating benefit, follow-up and new medicines.
- NABP: Buy medication safelyPharmacy regulator association · Tools for checking online pharmacies and recognizing unsafe sellers.
- MedlinePlus: FatigueUS National Library of Medicine · Fatigue has many causes that may need evaluation.
- NHLBI: Sleep apnea symptomsNIH patient education · Sleep-related breathing symptoms and evaluation.
- CoreAge Rx: Sermorelin product pageProvider primary source · Live product page; starting price is not a verified checkout total.
- Lavender Sky Health: Service pricingProvider service page · Medical service charges must be distinguished from medication charges.